Шығарылым |
Атауы |
Файл |
Том 13, № 4 (2019) |
Elevated Levels of Serum Exosomes in Patients with Major Depressive Disorder |
 (Eng)
|
Yakovlev A., Druzhkova T., Nikolaev R., Kuznetsova V., Gruzdev S., Guekht A., Gulyaeva N.
|
Том 13, № 4 (2019) |
Lipid Peroxidation Products in the Blood Plasma of Patients with Parkinson’s Disease as Possible Biomarkers of Different Stages of the Disease |
 (Eng)
|
Fedorova T., Logvinenko A., Poleshchuk V., Muzychuk O., Shabalina A., Illarioshkin S.
|
Том 13, № 4 (2019) |
Lipid Peroxidation and the Antioxidant System in the Blood of Epileptic Patients |
 (Eng)
|
Zharkinbekova N., Ormanov N.
|
Том 13, № 2 (2019) |
Genes Encoding Erythropoietin and Its Receptor in Bipolar I (Manic Phase) Patients as a Novel Diagnostic Agent: A Case-Control Study |
 (Eng)
|
Moradi M., Saidijam M., Ghaleiha A., Jahangard L., Yadegarazari R., Keshavarzi A.
|
Том 12, № 4 (2018) |
Blood-Serum Glutamate in Patients with Depressive Disorders as a Potential Peripheral Marker of the Prognosis of the Effectiveness of Therapy |
 (Eng)
|
Losenkov I., Boiko A., Levchuk L., Simutkin G., Bokhan N., Ivanova S.
|
Том 12, № 3 (2018) |
Caspase Activity and Expression in Lymphocytes of Patients with Borderline Personality Disorders |
 (Eng)
|
Yakovlev A., Druzhkova T., Guekht A., Gulyaeva N.
|
Том 12, № 3 (2018) |
Neuroautoimmune Processes in Vibration Disease |
 (Eng)
|
Bodienkova G., Kurchevenko S., Rusanova D.
|
Том 12, № 1 (2018) |
Comparative Studies of Glutamine Synthetase Levels in the Brains of Patients with Schizophrenia and Mentally Healthy People |
 (Eng)
|
Boksha I., Tereshkina E., Savushkina O., Prokhorova T., Vorobyeva E., Burbaeva G.
|
Том 12, № 1 (2018) |
Thiol/Disulfide Homeostasis in Schizophrenic Patients |
 (Eng)
|
Kulaksizoglu B., Kulaksizoglu S.
|
Том 12, № 1 (2018) |
The State of Albumin Thiol Groups in Patients with the First Episode of Schizophrenia |
 (Eng)
|
Brilliantova V., Smolina N., Syreishchikova T., Uzbekov M., Dobretsov G.
|
Том 11, № 4 (2017) |
The state of systemic oxidative stress during Parkinson’s disease |
 (Eng)
|
Fedorova T., Logvinenko A., Poleshchuk V., Illarioshkin S.
|
Том 11, № 2 (2017) |
Neurohumoral markers that predict the efficiency of pharmacologic therapy of depressive disorders |
 (Eng)
|
Levchuk L., Vyalova N., Simutkin G., Bokhan N., Ivanova S.
|
Том 11, № 1 (2017) |
The relationship between metabolic syndrome, BDNF, and vitamin D in patients with schizophrenia |
 (Eng)
|
Kulaksizoglu S., Kulaksizoglu B.
|
Том 11, № 1 (2017) |
Changes in the level of ciliary neurotrophic factor are related to the degree of severity of epilepsy |
 (Eng)
|
Musina L., Uzbekov M.
|
Том 10, № 3 (2016) |
Brain-derived neurotrophic factor in patients with age-related cataract |
 (Eng)
|
Shpak A., Guekht A., Druzhkova T., Kozlova K., Golovin A., Gulyaeva N.
|
Том 10, № 2 (2016) |
Increased ratios of homocysteine/vitamin B12, homocysteine/folate and methionine/vitamin B12 in schizophrenic patients |
 (Eng)
|
Kulaksızoglu B., Kulaksızoglu S., Ellidag H., Cinemre B., Baykal A., Yılmaz N.
|
Том 10, № 1 (2016) |
The relationship between the cytokine concentrations and levels of antibodies to neuronal proteins in workers who were exposed to vibration |
 (Eng)
|
Bodienkova G., Kurchevenko S.
|
Том 10, № 1 (2016) |
Gender differences in the plasma lipid profile and cellular lipid peroxidation intensity in diabetic patients with distal symmetrical polyneuropathy |
 (Eng)
|
Djordjevic G., Ljubisavljevic S.
|
Том 10, № 1 (2016) |
Evaluation of the level of substance P in patients with ischemic stroke in the acute phase |
 (Eng)
|
Levashova O., Kukhtevich I., Zolkornyaev I., Aleshina N., Kuptsova M.
|
Нәтижелер 19 - 1/19 |
|